VirBio (VIR)
Develops immune-based medicines for chronic hepatitis delta, solid tumors, and HIV cure research.
$11.40
After hours−0.09 (−0.80%)
At close$11.49(+5.63%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$0.74
Revenue estimate
$865.1K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.76−$0.88−$0.80−$1.17−$0.31−$0.85$0.47Pending
Estimate−$0.85−$0.83−$0.72−$0.70−$0.42−$0.01$0.33−$0.74
Surprise+10.6%−6.0%−11.1%−67.1%+26.2%−8,400.0%+41.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$12.4M$1.8M$1.2M$240.0K$64.1M−$29.0K$238.9MPending
Estimate$8.1M$8.6M$2.7M$19.9M$19.9M$55.5M$135.9M$865.1K
Surprise+52.0%−79.1%−55.4%−98.8%+221.9%−100.1%+75.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.61 | — | — |
| Sep 2028 | −$0.64 | — | — |
| Jun 2028 | −$0.66 | — | — |
| Mar 2028 | −$0.65 | — | — |
| Dec 2027 | −$0.64 | — | — |
| Sep 2027 | −$0.63 | — | — |
| Jun 2027 | −$0.65 | — | — |
| Mar 2027 | −$0.51 | — | — |
| Dec 2026 | −$0.66 | — | — |
| Nov 2026 | −$0.74 | — | — |
| Aug 2026 | $0.33 | $0.47 | +41.3% |
| May 2026 | −$0.01 | −$0.85 | −8,400.0% |
| Feb 2026 | −$0.42 | −$0.31 | +26.2% |
| Nov 2025 | −$0.70 | −$1.17 | −67.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Oct 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.61 | — | — | $16.7M | — | — | — |
| Sep 2028 | −$0.64 | — | — | $8.0M | — | — | — |
| Jun 2028 | −$0.66 | — | — | $50.0M | — | — | — |
| Mar 2028 | −$0.65 | — | — | $50.0M | — | — | — |
| Dec 2027 | −$0.64 | — | — | $25.6M | — | — | — |
| Sep 2027 | −$0.63 | — | — | $10.3M | — | — | — |
| Jun 2027 | −$0.65 | — | — | $10.8M | — | — | — |
| Mar 2027 | −$0.51 | — | — | $36.4M | — | — | — |
| Dec 2026 | −$0.66 | — | — | $5.5M | — | — | — |
| Nov 4, 2026 | −$0.74 | — | — | $865.1K | — | — | — |
| Aug 5, 2026 | $0.33 | $0.47 | +41.3% | $135.9M | $238.9M | +75.8% | −3.7% |
| May 6, 2026 | −$0.01 | −$0.85 | −8,400.0% | $55.5M | −$29.0K | −100.1% | −9.9% |
| Feb 23, 2026 | −$0.42 | −$0.31 | +26.2% | $19.9M | $64.1M | +221.9% | +27.7% |
| Nov 5, 2025 | −$0.70 | −$1.17 | −67.1% | $19.9M | $240.0K | −98.8% | −5.2% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 26, 2020 | |||||||
| Nov 19, 2019 | |||||||
| Oct 10, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |